Home > Medical Research Archives > Issue 149 > A Systematic Review of the Efficacy and Safety of Favipiravir (Avigan) for the Treatment of Novel COVID-19 Infections
Published in the Medical Research Archives
Aug 2020 Issue
A Systematic Review of the Efficacy and Safety of Favipiravir (Avigan) for the Treatment of Novel COVID-19 Infections
Published on Aug 24, 2020
DOI
Abstract
Since the emergence of SARS-CoV-2 infection in Wuhan, China, in December 2019, the spread has caused COVID19 disease in over 8.1 million people and more than 439 thousand deaths across the globe as on 16th June 2020. Absence of any particular cure or vaccine lead the health care system to treat the patients with the existing potential antiviral drugs. Recently, Favipiravir, a potential RdRp inhibitor of SARS-COV-2 sheds the ray of hope for treating COVID-19 patients efficiently.
Author info
Subhendu Bag, Sayantan Sinha, Isao Saito
Author Area
Have an article to submit?
Submission Guidelines
Submit a manuscript
Become a member
